KRC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
KRC is not a good buy right now for a Beginner focused on long-term investing, even with $50,000-$100,000 to deploy. The setup is neutral-to-weak, Wall Street sentiment is mostly Hold/Neutral with recent target cuts, insiders are actively selling, and there is no fresh catalyst to justify an aggressive entry. For an impatient investor who does not want to wait for a better setup, the clearer decision is to avoid buying now.
Pre-market price is 35.11, sitting just above pivot support at 34.206 and below resistance at 35.371. MACD histogram is slightly positive at 0.0527 but contracting, which weakens momentum. RSI_6 at 62.69 is neutral and not oversold. Moving averages are converging, suggesting a range-bound rather than strong uptrend. Overall technicals show a mild rebound attempt, but not a convincing bullish trend.
["Options open interest put-call ratio of 0.55 leans slightly bullish.", "Analysts have at least one recent price target increase from Evercore ISI to $38 from $33.", "Similar candlestick pattern data suggests possible near-term upside of 4.03% in one week and 7.3% in one month."]
["No news in the recent week, so there is no event-driven catalyst.", "Several analysts cut price targets recently, including JPMorgan, Deutsche Bank, Barclays, Scotiabank, and Mizuho.", "Recent analyst stance remains mostly Neutral/Hold/In Line, with only one Underperform downgrade but no bullish consensus.", "Insiders are selling, and selling activity increased 139.22% over the last month.", "Hedge funds are neutral with no significant positive trading trends.", "The stock is tied to office REIT weakness and concerns around AI disruption, high rates, and West Coast credit risk."]
No usable latest-quarter financial snapshot was provided because of the data error, so I cannot confirm recent revenue, FFO, or margin trends. Based on the analyst notes, expectations for FY26 and FY27 FFO were trimmed slightly, which implies a softer forward growth outlook. The latest quarter season was not explicitly provided in the dataset.
Wall Street remains cautious. The recent trend shows multiple target reductions over the last few months, with Deutsche Bank cutting to $33 and maintaining Hold, JPMorgan cutting to $39 and staying Neutral, Barclays cutting to $31 and Equal Weight, and Mizuho downgrading to Underperform with a $29 target. Evercore raised its target to $38, but still kept only an In Line rating. Overall pros and cons view: pros are limited, centered on valuation support and a possible near-term rebound; cons dominate, including sector underperformance, AI disruption fears, higher-rate pressure, and office-specific credit/moveout concerns.
